Quantcast

Latest Immunoglobulin E Stories

8e205849d8535e18b52ce0817598fa801
2009-12-15 15:40:00

Mizzou scientists point to an imbalance of white blood cells in newborns As soon as babies are born, they are susceptible to diseases and infections, such as jaundice and e-coli. For up to a month, their immune systems aren't adequately developed to fight diseases. Although these infections are often minor, they can lead to serious problems if left untreated. To help strengthen newborns' immune systems, University of Missouri researchers have pinpointed a group of depleted white blood cells,...

2009-10-18 12:55:56

Macrophages, the scavenger cells of the body's immune system, are responsible for disposing of dying cells. Stanford University School of Medicine researchers have identified one pathway in this important process in mice that, if disrupted, causes a lupuslike autoimmune disease. The findings could lead to both a better understanding of the cause of lupus in humans and potential drug treatments for the disorder, which affects an estimated 1.5-2 million people in the United States. "Just like...

2009-06-22 05:00:00

Asthma and allergy sufferers have an alternative to Singulair and Zicam - The ALCAT Test WARSAW, Poland, June 22 /PRNewswire/ -- Last week the FDA knocked the wind out of asthmatics by requesting the manufacturers of Singulair, a popular leukotriene blocking asthma and allergy drug, to upgrade their warning against psychotic side effects. Further respiratory distress was imposed on Zicam users when the FDA also last week announced warnings that the drug may cause a loss of smell. What's an...

2009-04-30 09:59:41

Folic acid, or vitamin B9, essential for red blood cell health and long known to reduce the risk of spinal birth defects, may also suppress allergic reactions and lessen the severity of allergy and asthma symptoms, according to new research from the Johns Hopkins Children's Center. In what is believed to be the first study in humans examining the link between blood levels of folate "“ the naturally occurring form of folic acid "” and allergies, the Hopkins scientists say results...

92365227d48105f53ed411c249b276f51
2009-01-30 09:38:58

Research published in the Journal of Leukocyte Biology identifies eotaxin as a novel drug target If you've ever wondered why some allergic reactions progress quickly and may even become fatal, a new research report published in the February 2009 issue of the Journal of Leukocyte Biology provides an important part of the answer. In the report, scientists from Queen's University of Belfast, University of Oxford and Trinity College Dublin show for the first time that eotaxin, a chemical that...

2008-12-04 07:36:00

GAITHERSBURG, Md., Dec. 4 /PRNewswire/ -- MedImmune today announced that it has initiated a Phase 2 clinical trial in patients with chronic asthma to determine the safety of subcutaneous dosing of a humanized monoclonal antibody (MAb) that targets the interleukin-5 receptor (IL-5R). Preclinical data suggest that inhibiting the IL-5R pathway may lead to a targeted approach for treating patients with asthma, supporting continued study of this antibody. "Asthma can be a very...

2008-09-22 18:00:12

RESEARCH TRIANGLE PARK, N.C., Sept. 22, 2008 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today, at the 15th International Inflammation Research Association Conference in Chantilly, Virginia, results from a preclinical study demonstrating effects of senicapoc in isolated human lung mast cells. Senicapoc, the Company's novel orally available small molecule inhibitor of the KCa3.1 potassium ion channel, was shown to potently block KCa3.1 potassium currents in isolated human lung mast...

2008-09-15 18:00:37

MD Biosciences, a global biotechnology company focused in inflammations & neurology research will showcase its inflammations related pre-clinical services and research products at the 15th International Inflammation Research Association (IRA) Conference, September 21-24, Chantilly, VA. Capabilities featured will be pre-clinical efficacy disease models and research products for drug discovery and research. MD Biosciences will be hosting a lunch and learn session titled "Discovery of...

2008-09-02 03:00:00

MARTINSRIED, Germany, Sept. 2, 2008 (GLOBE NEWSWIRE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment, TecDAX) announced today the publication of a first data package for its most advanced proprietary drug development program MOR103, a fully human HuCAL antibody directed against GM-CSF, in the journal "Molecular Immunology". The data presented show that MOR103 is able to block disease-relevant processes such as GM-CSF dependent proliferation and signal transduction in vitro....

2008-07-14 15:00:00

Allergic diseases appear more often in children who grow up near busy roads, researchers in Germany said. Helmholtz Zentrum Munchen, a German research group, studied over six years whether associations are identifiable between the onset of atopic diseases and exposure to air pollutants originating from traffic. Study leader Dr. Joachim Heinrich compared the data of 3,061 6-year old children from Munich and its surroundings, who had been tracked from birth. The appearance of the specific IgE...


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related